Stem Cells Spin S.A. (WSE:SCS)
0.3220
+0.0020 (0.63%)
At close: Jul 16, 2025
Stem Cells Spin Revenue
Stem Cells Spin had revenue of 7.94K PLN in the quarter ending March 31, 2025, with 85.42% growth. This brings the company's revenue in the last twelve months to 57.94K, down -84.43% year-over-year. In the year 2024, Stem Cells Spin had annual revenue of 54.28K, down -87.06%.
Revenue (ttm)
57.94K
Revenue Growth
-84.43%
P/S Ratio
199.78
Revenue / Employee
57.94K
Employees
1
Market Cap
11.57M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 54.28K | -365.04K | -87.06% |
Dec 31, 2023 | 419.32K | 170.96K | 68.84% |
Dec 31, 2022 | 248.36K | -277.56K | -52.78% |
Dec 31, 2021 | 525.92K | 257.60K | 96.00% |
Dec 31, 2020 | 268.32K | -313.83K | -53.91% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.82B |
Voxel | 556.98M |
Synektik Spólka Akcyjna | 592.94M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |
EMC Instytut Medyczny | 836.81M |